Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
NCT ID: NCT06953622
Last Updated: 2025-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
330 participants
OBSERVATIONAL
2024-01-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patent Foramen Ovale Closure in Migraine
NCT06192173
COMPETE Cohort Study
NCT06033937
COMParison of the EffecT of dEvice Closure in Alleviating Migraine With PFO (COMPETE-2)
NCT05561660
pLatelEts And MigRaine iN patEnt foRamen Ovale
NCT03521193
Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale
NCT05546320
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conservative group
Don't use antiplatelet drugs or undergo patent foramen ovale closure.
Conservative treatment
Receive no antipaletet drug treatment and surgery
Antiplatelet group
The application of antiplatelet drug.
Antipaletet drug
Use of antipaletet drugs.
PFO group
Receive a patent foramen ovale closure surgery.
Patent Foramen Ovale Closure
Receive the surgery of Patent Foramen Ovale
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conservative treatment
Receive no antipaletet drug treatment and surgery
Antipaletet drug
Use of antipaletet drugs.
Patent Foramen Ovale Closure
Receive the surgery of Patent Foramen Ovale
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmation of patent foramen ovale through transthoracic echocardiography(TTE) or transesophageal echocardiography(TEE)/right heart contrast echocardiography
* Agree to participate in the study and sign the informed consent form.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Third Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University Third Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M2024296
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.